Literature DB >> 20721604

Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug.

Deng-Guang Yu1, Li-Dong Gao, Kenneth White, Christopher Branford-White, Wei-Yue Lu, Li-Min Zhu.   

Abstract

PURPOSE: To design and fabricate multicomponent amorphous electrospun nanofibers for synergistically improving the dissolution rate and permeation profiles of poorly water-soluble drugs.
METHODS: Nanofibers were designed to be composed of a poorly water soluble drug, helicid, a hydrophilic polymer polyvinylpyrrolidone as filament-forming matrix, sodium dodecyl sulfate as transmembrane enhancer and mannitol as taste masking agent, and were prepared from hot aqueous co-dissolving solutions of them. An elevated temperature electrospinning process was developed to fabricate the composite nanofibers, which were characterized using FESEM, DSC, XRD, ATR-FTIR, in vitro dissolution and permeation tests.
RESULTS: The composite nanofibers were homogeneous with smooth surfaces and uniform structure, and the components were combined together in an amorphous state because of the favorable interactions such as hydrogen bonding, electrostatic interaction and hydrophobic interactions among them. In vitro dissolution and permeation tests demonstrated that the composite nanofibers had a dissolution rate over 26-fold faster than that of crude helicid particles and a 10-fold higher permeation rate across sublingual mucosa.
CONCLUSIONS: A new type of amorphous material in the form of nanofibers was prepared from hot aqueous solutions of multiple ingredients using an electrospinning process. The amorphous nanofibers were able to improve the dissolution rate and permeation rate of helicid.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20721604     DOI: 10.1007/s11095-010-0239-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Characterization of captopril sublingual permeation: determination of preferred routes and mechanisms.

Authors:  D J Chetty; L L Chen; Y W Chien
Journal:  J Pharm Sci       Date:  2001-11       Impact factor: 3.534

2.  Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning.

Authors:  Geert Verreck; Iksoo Chun; Jef Peeters; Joel Rosenblatt; Marcus E Brewster
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

3.  Material science. Spinning continuous fibers for nanotechnology.

Authors:  Yuris Dzenis
Journal:  Science       Date:  2004-06-25       Impact factor: 47.728

4.  Safe and effective permeation enhancers for oral drug delivery.

Authors:  Kathryn Whitehead; Natalie Karr; Samir Mitragotri
Journal:  Pharm Res       Date:  2007-12-05       Impact factor: 4.200

Review 5.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 6.  Micro- and nanoparticulates.

Authors:  Andrew A Moshfeghi; Gholam A Peyman
Journal:  Adv Drug Deliv Rev       Date:  2005-11-17       Impact factor: 15.470

7.  Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR.

Authors:  Adchara Pongpeerapat; Kenjirou Higashi; Yuichi Tozuka; Kunikazu Moribe; Keiji Yamamoto
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

8.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

9.  Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study.

Authors:  Munish Kumar Dhiman; Anupama Dhiman; Krutika K Sawant
Journal:  AAPS PharmSciTech       Date:  2009-03-12       Impact factor: 3.246

10.  Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.

Authors:  Lichen Yin; Jieying Ding; Chunbai He; Liming Cui; Cui Tang; Chunhua Yin
Journal:  Biomaterials       Date:  2009-07-16       Impact factor: 12.479

View more
  7 in total

1.  Preparation and Evaluation of Polyvinylpyrrolidone Electrospun Nanofiber Patches of Pioglitazone for the Treatment of Atopic Dermatitis.

Authors:  Rana Obaidat; Ayat Abu Shameh; Mohannad Aljarrah; Rania Hamed
Journal:  AAPS PharmSciTech       Date:  2022-01-10       Impact factor: 3.246

2.  Solid dispersions in the form of electrospun core-sheath nanofibers.

Authors:  Deng-Guang Yu; Li-Min Zhu; Christopher J Branford-White; Jun-He Yang; Xia Wang; Ying Li; Wei Qian
Journal:  Int J Nanomedicine       Date:  2011-12-13

3.  Influence of Working Temperature on The Formation of Electrospun Polymer Nanofibers.

Authors:  Guang-Zhi Yang; Hai-Peng Li; Jun-He Yang; Jia Wan; Deng-Guang Yu
Journal:  Nanoscale Res Lett       Date:  2017-01-19       Impact factor: 4.703

4.  A Portable Device for the Generation of Drug-Loaded Three-Compartmental Fibers Containing Metronidazole and Iodine for Topical Application.

Authors:  Francis Brako; Chaojie Luo; Rupy Kaur Matharu; Lena Ciric; Anthony Harker; Mohan Edirisinghe; Duncan Q M Craig
Journal:  Pharmaceutics       Date:  2020-04-18       Impact factor: 6.321

Review 5.  Research progress, models and simulation of electrospinning technology: a review.

Authors:  Yajin Guo; Xinyu Wang; Ying Shen; Kuo Dong; Linyi Shen; Asmaa Ahmed Abdullah Alzalab
Journal:  J Mater Sci       Date:  2021-10-13       Impact factor: 4.220

6.  Electrospun poly(L-lactide) fiber with ginsenoside rg3 for inhibiting scar hyperplasia of skin.

Authors:  Wenguo Cui; Liying Cheng; Changmin Hu; Haiyan Li; Yuguang Zhang; Jiang Chang
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

7.  Glutaraldehyde-crosslinked chitosan-polyethylene oxide nanofibers as a potential gastroretentive delivery system of nizatidine for augmented gastroprotective activity.

Authors:  Walaa Ebrahim Abd El Hady; Osama Abd El-Aazeem Soliman; Hassan Mohamed El Sabbagh; Elham Abdelmonem Mohamed
Journal:  Drug Deliv       Date:  2021-08-24       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.